Skip to content
healthcare.dev

Novolin 70/30

NDC 0169-3007, Human Insulin, injection, suspension, from Novo Nordisk Pharmaceutical Industries, LP.

Product NDC
0169-3007
Status
Listed
Labeler
Novo Nordisk Pharmaceutical Industries, LP
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Product type
HUMAN OTC DRUG
Marketing category
BLA
Application
BLA019991
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-3007 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN HUMAN100 [iU]/mL

Pharmacologic classes

Insulin [CS]; Insulin [EPC]

Package NDCNDC-11Package
0169-3007-15001693007155 SYRINGE, PLASTIC in 1 CARTON (0169-3007-15) / 3 mL in 1 SYRINGE, PLASTIC (0169-3007-01)
0169-3007-25001693007255 SYRINGE, PLASTIC in 1 CARTON (0169-3007-25) / 3 mL in 1 SYRINGE, PLASTIC (0169-3007-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00169300715

    GET /v1/drugs/nadac/00169300715

Use it

Look up 0169-3007 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-3007 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-3007. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.